Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;31(9):1174-80.
doi: 10.1177/0883073816650033. Epub 2016 Jun 1.

Atypical Manifestations in Glut1 Deficiency Syndrome

Affiliations

Atypical Manifestations in Glut1 Deficiency Syndrome

V De Giorgis et al. J Child Neurol. 2016 Aug.

Abstract

Glucose transporter type 1 deficiency syndrome is a genetically determined, treatable, neurologic disorder that is caused by an insufficient transport of glucose into the brain. It is caused by a mutation in the SCL2A1 gene, which is so far the only known to be associated with this condition. Glucose transporter type 1 deficiency syndrome consists of a wide clinical spectrum that usually presents with cognitive impairment, epilepsy, paroxysmal exercise-induced dyskinesia, acquired microcephaly, hemolytic anemia, gait disturbance, and dyspraxia in different combinations. However, there are other clinical manifestations that we consider equally peculiar but that have so far been poorly described in literature. In this review, supported by a video contribution, we will accurately describe this type of clinical manifestation such as oculogyric crises, weakness, paroxysmal kinesigenic and nonkinesigenic dyskinesia in order to provide an additional instrument for a correct, rapid diagnosis.

Keywords: GLUT1DS; SCL2A1; fatigue; oculogyric crises; paroxysmal kinesigenic dyskinesia; paroxysmal nonkinesigenic dyskinesia.

PubMed Disclaimer

MeSH terms

Substances

Supplementary concepts